The general surgery devices market covers wide-ranging devices used in diagnostic and surgical procedures primarily for the gastrointestinal tract, abdomen, and pelvis. Embolization is a procedure that uses particles such as tiny gelatin sponges or beads to block a blood vessel. GlobalData uses proprietary data and analytics to provide a comprehensive report on the embolization particles market in the US. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the embolization particles market in the US was Boston Scientific followed by Cook Medical, Merit Medical Systems, Sirtex Medical, Terumo and Varian Medical Systems.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Embolization particles are used to stop bleeding or are used to block the flow of blood to a tumor. These particles are generally used to treat liver cancer, renal cell carcinoma, kidney cancer, neuroendocrine tumors, arteriovenous malformation, uterine fibroids and benign prostatic hyperplasia. Despite similar appearances and handling characteristics, each one of the embolic agents has specific physical and chemical properties that affect their in vivo behavior. Clinicians have to familiarize themselves with these differences to make the correct choice of embolic agent, and then use the correct protocol for embolization. The sizes of embolization particles can range from 30 to 1200 µm, depending on the indication. Drug-eluting beads, microspheres, Poly Vinyl Alcohol (PVA) Particles and Radioembolization Particles are considered in this market.
The embolization particles market in the US can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size embolization particles in the US, buy the report here.